- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05575947
Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch Bariatric Surgical Procedures
A Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch (DS) Bariatric Surgical Procedures
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To compare the safety and effectiveness of robotic-assisted Duodenal-Switch Bariatric Surgical Procedures (including Biliopancreatic Diversion-Duodenal-Switch/BPD-DS, Single Anastomosis- Duodeno Ileal Bypass with Sleeve/SADI-S, and One Anastomosis Duodenal Switch/OADS) with laparoscopic approaches using real world data (RWD) from the Premier Healthcare Database (PHD). The study endpoints include:
Safety Related Outcomes
- Intraoperative Complication Rates
- Transfusion Rates
- 30-Day Post-Operative Complication Rates*
- 30-Day Readmission Rates*
- 30-Day Reoperation Rates*
- 30-Day Mortality*
Effectiveness Related Outcomes
- Conversion Rate to Open Surgery
- Operative Time
- Length of Hospital Stay
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Sunnyvale, California, United States, 94086
- Intuitive Surgical
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria-
- Patients who are ≥ 18 years old and had a primary laparoscopic or robotic-assisted bariatric surgery procedure with a duodenal switch (DS) defined herein as BPD-DS, SADI-S, or OADS; and,
Met one of the below qualifications:
- Body mass index (BMI) > 40 kg/m2 OR
- BMI > 35 kg/m2 and had one of the following obesity-related co-morbidities such as type II diabetes mellitus, hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease according to the US Centers of Medicare & Medicaid Services (CMS) criteria for the use of bariatric surgery in adults
Exclusion Criteria-
- Were diagnosed with cancer; or
- Underwent an outpatient DS bariatric surgical procedure; or
- Underwent an emergent DS bariatric surgical procedure; or
- Underwent a DS procedure concomitant to a different primary procedure (i.e., colon resection)
- Underwent a revisional DS bariatric surgical procedure (i.e., patient had a prior bariatric procedure within three (3) years of the DS procedure)
- Have missing operating room (OR) time data (i.e., incomplete billing record)
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
robotic-assisted
Robotic-assisted cases converted to open will be part of the robotic cohort. Comparison of the following safety and effectiveness related surgical outcomes across robotic-assisted and laparoscopic cohorts: Safety Related Outcomes
Effectiveness Related Outcomes
|
da Vinci Surgical System
|
|
laparoscopic
Laparoscopic cases converted to open will be part of the laparoscopic cohort. Comparison of the following safety and effectiveness related surgical outcomes across robotic-assisted and laparoscopic cohorts: Safety Related Outcomes
Effectiveness Related Outcomes
|
laparoscopic bariatric surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative Complication Rates (Safety)
Time Frame: Intraoperative
|
Incidence of complications occuring intraoperatively
|
Intraoperative
|
|
Transfusions (Safety)
Time Frame: perioperative
|
Transfusion Rates Rate of transfusion that occur intraoperatively and postoperatively
|
perioperative
|
|
30-Day Post-Operative Complication Rates (Safety)
Time Frame: Intraoperative to 30-days (from the date of surgery upto 30-days)
|
Incidence of complications that occur after surgery to 30-days
|
Intraoperative to 30-days (from the date of surgery upto 30-days)
|
|
30-Day Readmission Rates (Safety)
Time Frame: Upto 30 days
|
Incidence of readmission that occur after discharge
|
Upto 30 days
|
|
30-Day Reoperation Rates (Safety)
Time Frame: upto 30 days following the documented date of the surgery
|
Incidence of reoperations that occur after till 30 days
|
upto 30 days following the documented date of the surgery
|
|
30-day Mortality Rate (Safety)
Time Frame: Intra-operative to 30-days
|
Incidence of mortality until 30 days
|
Intra-operative to 30-days
|
|
Conversion rate to open surgery (Effectiveness)
Time Frame: Intraoperative
|
Incidence of conversion to open that occur intraoperatively
|
Intraoperative
|
|
Operative Time (Effectiveness)
Time Frame: Intraoperative
|
Amount of time it takes to complete the procedure (in min)
|
Intraoperative
|
|
Length of hospital Stay (Effectiveness)
Time Frame: perioperative
|
Number of days participant is in the hospital
|
perioperative
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Usha L Kreaden, Intuitive Surgical
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Bariatric surgery
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.